miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells

American Journal of Physiology - Gastrointestinal and Liver Physiology

Volumn 299, Issue 3, 2010, Pages

  Sansom, Sarah E ^a   Nuovo, Gerard J ^a,c   Martin, Mickey M ^a   Kotha, Sainath R ^a,b   Parinandi, Narasimham L ^a,b   Elton, Terry S ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Gastrointestinal system; miRNAs

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; LUCIFERASE; MICRORNA; MICRORNA 802; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN802 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ARTICLE; BIOINFORMATICS; COLON; CONTROLLED STUDY; ELECTRIC RESISTANCE; FEMALE; GASTROINTESTINAL TRACT; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INTESTINE; INTESTINE EPITHELIUM CELL; LOSS OF FUNCTION MUTATION; NONHUMAN; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; REPORTER GENE; SIGNAL TRANSDUCTION; VALIDATION STUDY; ANIMAL; CHO CELL; CRICETULUS; CYTOLOGY; GENETICS; HAMSTER; HISTOLOGY; INTESTINE MUCOSA; METABOLISM; SMALL INTESTINE; SMOOTH MUSCLE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANIMALS; CELL LINE, TUMOR; CHO CELLS; COLON; CRICETINAE; CRICETULUS; HUMANS; INTESTINAL MUCOSA; INTESTINE, SMALL; MICRORNAS; MUSCLE, SMOOTH; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, MESSENGER;

EID: 77956995123     PISSN: 01931857     EISSN: 15221547     Source Type: Journal    
DOI: 10.1152/ajpgi.00120.2010     Document Type: Article

References (63)

1. Alexiou P, Maragkakis M, Papadopoulos GL, Reczko M, Hatzigeorgiou AG. Lost in translation: an assessment and perspective for computational microRNA target identification. Bioinformatics 25: 3049-3055, 2009.
2. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
3. Beleslin DB. The effect of angiotensin on the peristaltic reflex of the isolated guinea-pig ileum. Br J Pharmacol 32: 583-590, 1968.
4. Berk BC. Angiotensin type 2 receptor (AT2R): a challenging twin. Sci STKE 181: PE16, 2003.
5. Bolton JE, Munday KA, Parsons BJ, York BG. Effects of angiotensin II on fluid transport, transmural potential difference and blood flow by rat jejunum in vivo. J Physiol 253: 411-428, 1975.
6. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 23: 175-205, 2007.
7. Byrnes JJ, Gross S, Ellard C, Connolly K, Donahue S, Picarella D. Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice. Inflamm Res 58: 819-827, 2009.
8. Carl-McGrath S, Ebert MP, Lendeckel U, Röcken C. Expression of the local angiotensin II system in gastric cancer may facilitate lymphatic invasion and nodal spread. Cancer Biol Ther 6: e1-e9, 2007.
9. Casselbrant A, Edebo A, Wennerblom J, Lönroth H, Helander HF, Vieth M, Lundell L, Fändriks L. Actions by angiotensin II on esophageal contractility in humans. Gastroenterology 132: 249-260, 2007.
10. Casselbrant A, Edebo A, Hallersund P, Spak E, Helander HF, Jönson C, Fändriks L. Angiotensin II receptors are expressed and functional in human esophageal mucosa. Am J Physiol Gastrointest Liver Physiol 297: G1019-G1027, 2009.
11. Cox HM, Cuthbert AW, Munday KA. The effect of angiotensin II upon electrogenic ion transport in rat intestinal epithelia. Br J Pharmacol 90: 393-401, 1987.
12. Davidson-Moncada J, Papavasiliou FN, Tam W. MicroRNAs of the immune system: roles in inflammation and cancer. Ann NY Acad Sci 1183: 183-194, 2010.
13. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International Union of Pharmacology XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
14. DuBois RN. Cyclooxygenase-2 and colorectal cancer. Prog Exp Tumor Res 37: 124-137, 2003.
15. DuBois RN, Shao J, Tsujii M, Sheng H, Beauchamp RD. G1 delay in cells overexpressing prostaglandin endoperoxide synthase-2. Cancer Res 56: 733-737, 1996.
16. Ewert S, Spak E, Olbers T, Johnsson E, Edebo A, Fändriks L. Angiotensin II induced contraction of rat and human small intestinal wall musculature in vitro. Acta Physiol (Oxf) 188: 33-40, 2006.
17. Fishlock DJ, Gunn A. The action of angiotensin on the human colon in vitro. Br J Pharmacol 39: 34-39, 1970.
18. Friedman RC, Farh KK, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105, 2009.
19. Fujimura T, Ohta T, Oyama K, Miyashita T, Miwa K. Role of cyclooxygenase-2 in the carcinogenesis of gastrointestinal tract cancers: a review and report of personal experience. World J Gastroenterol 12: 1336-1345, 2006.
20. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ. miRBase: tools for microRNA genomics. Nucleic Acids Res 36 (Database issue): D154-D158, 2008.
21. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105, 2007.
22. Hirasawa K, Sato Y, Hosoda Y, Yamamoto T, Hanai H. Immunohistochemical localization of angiotensin II receptor and local renin-angiotensin system in human colonic mucosa. J Histochem Cytochem 50: 275-282, 2002.
23. Inokuchi Y, Morohashi T, Kawana I, Nagashima Y, Kihara M, Umemura S. Amelioration of 2,4,6-trinitrobenzene sulphonic acid induced colitis in angiotensinogen gene knockout mice. Gut 54: 349-356, 2005.
24. Jaszewski R, Tolia V, Ehrinpreis MN, Bodzin JH, Peleman RR, Korlipara R, Weinstock JV. Increased colonic mucosal angiotensin I and II concentrations in Crohn's colitis. Gastroenterology 98: 1543-1548, 1990.
25. Jin XH, Wang ZQ, Siragy HM, Guerrant RL, Carey RM. Regulation of jejunal sodium and water absorption by angiotensin subtype receptors. Am J Physiol Regul Integr Comp Physiol 275: R515-R523, 1998.
26. Katada K, Yoshida N, Suzuki T, Okuda T, Mizushima K, Takagi T, Ichikawa H, Naito Y, Cepinskas G, Yoshikawa T. Dextran sulfate sodium-induced acute colonic inflammation in angiotensin II type 1a receptor deficient mice. Inflamm Res 57: 84-91, 2008.
27. 2+ and permeability. Am J Physiol Lung Cell Mol Physiol 274: L810-L819, 1998.
28. Kertesz M, Iovino N, Unnerstall U, Gaul U, Segal E. The role of site accessibility in microRNA target recognition. Nat Genet 39: 1278-1284, 2007.
29. Kinoshita J, Fushida S, Harada S, Yagi Y, Fujita H, Kinami S, Ninomiya I, Fujimura T, Kayahara M, Yashiro M, Hirakawa K, Ohta T. Local angiotensin II-generation in human gastric cancer: correlation with tumor progression through the activation of ERK1/2, NF-kappaB and survivin. Int J Oncol 34: 1573-1582, 2009.
30. Kuhn DE, Nuovo GJ, Martin MM, Malana GE, Pleister AP, Jiang J, Schmittgen TD, Terry AV Jr, Gardiner K, Head E, Feldman DS, Elton TS. Human chromosome 21-derived miRNAs are overexpressed in down syndrome brains and hearts. Biochem Biophys Res Commun 370: 473-477, 2008.
31. Kuhn DE, Nuovo GJ, Terry AV Jr, Martin MM, Malana GE, Sansom SE, Pleister AP, Beck WD, Head E, Feldman DS, Elton TS. Chromosome 21-derived microRNAs provide an etiological basis for aberrant protein expression in human Down syndrome brains. J Biol Chem 285: 1529-1543, 2010.
32. Kuhn DE, Martin MM, Feldman DS, Terry AV Jr, Nuovo GJ, Elton TS. Experimental validation of miRNA targets. Methods 44: 47-54, 2008.
33. Levens NR. Control of intestinal absorption by the renin angiotensin system. Am J Physiol Gastrointest Liver Physiol 249: G3-G15, 1985.
34. Levens NR. Response of rat jejunum to changes in sodium and volume balance. Am J Physiol Gastrointest Liver Physiol 251: G413-G420, 1986.
35. Levens NR, Peach MJ, Carey RM. Interactions between angiotensin peptides and the sympathetic nervous system mediating intestinal sodium and water absorption in the rat. J Clin Invest 67: 1197-1207, 1981.
36. Levens NR, Peach MJ, Carey RM, Poat JA, Munday KA. Response of rat jejunum to angiotensin II: role of norepinephrine and prostaglandins. Am J Physiol Gastrointest Liver Physiol 240: G17-G24, 1981.
37. Lever AF, Hole DJ, Gillis CR, McCallum IR, McInnes GT, Mac- Kinnon PL, Meredith PA, Murray LS, Reid JL, Robertson JW. Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? Lancet 352: 179-184, 1998.
38. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20, 2005.
39. Ludtke FE, Golenhofen K, Schubert F. Angiotensin II stimulates human gastric smooth muscle in vitro. J Auton Pharmacol 9: 139-147, 1989.
40. Martin MM, Lee EJ, Buckenberger JA, Schmittgen TD, Elton TS. MicroRNA-155 regulates human angiotensin II type 1 receptor expression in fibroblasts. J Biol Chem 281: 18277-18284, 2006.
41. Martin MM, Buckenberger JA, Jiang J, Malana GE, Nuovo GJ, Chotani M, Feldman DS, Schmittgen TD, Elton TS. The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microrna-155 binding. J Biol Chem 282: 24262-24269, 2007.
42. Martin MM, Buckenberger JA, Jiang J, Malana GE, Knoell DL, Feldman DS, Elton TS. TGF-beta1 stimulates human AT1 receptor expression in lung fibroblasts by cross talk between the Smad, p38 MAPK, JNK, and PI3K signaling pathways. Am J Physiol Lung Cell Mol Physiol 293: L790-L799, 2007.
43. Mizushima T, Sasaki M, Ando T, Wada T, Tanaka M, Okamoto Y, Ebi M, Hirata Y, Murakami K, Mizoshita T, Shimura T, Kubota E, Ogasawara N, Tanida S, Kataoka H, Kamiya T, Alexander JS, Joh T. Blockage of angiotensin II type 1 receptor regulates TNF-alpha-induced MAdCAM-1 expression via inhibition of NF-kappaB translocation to the nucleus and ameliorates colitis. Am J Physiol Gastrointest Liver Physiol 298: G255-G266, 2010.
44. Musch MW, Li YC, Chang EB. Angiotensin II directly regulates intestinal epithelial NHE3 in Caco2BBE cells. BMC Physiol 9: 5, 2009.
45. Nakamura K, Matsui T, Adachi H, Yamagishi SI. Involvement of angiotensin II in intestinal cholesterol absorption. Pharmacol Res 61: 460-465, 2010.
46. Nuovo GJ, Elton TS, Nana-Sinkam P, Volinia S, Croce CM, Schmittgen TD. A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nat Protoc 4: 107-115, 2009.
47. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803, 2006.
48. Peterson MD, Mooseker MS. Characterization of the enterocyte-like brush border cytoskeleton of the C2BBe clones of the human intestinal cell line, Caco-2. J Cell Sci 102: 581-600, 1992.
49. Ray EC, Avissar NE, Salloum R, Sax HC. Growth hormone and epidermal growth factor upregulate specific sodium-dependent glutamine uptake systems in human intestinal C2BBe1 cells. J Nutr 135: 14-18, 2005.
50. Röcken C, Röhl FW, Diebler E, Lendeckel U, Pross M, Carl-McGrath S, Ebert MP. The angiotensin II/angiotensin II receptor system correlates with nodal spread in intestinal type gastric cancer. Cancer Epidemiol Biomarkers Prev 16: 1206-1212, 2007. (Pubitemid 46984960)
51. Schinke M, Doods HN, Ganten D, Wienen W, Entzeroth M. Characterization of rat intestinal angiotensin II receptors. Eur J Pharmacol 204: 165-170, 1991.
52. Sechi LA, Valentin JP, Griffin CA, Schambelan M. Autoradiographic characterization of angiotensin II receptor subtypes in rat intestine. Am J Physiol Gastrointest Liver Physiol 265: G21-G27, 1993.
53. Sheng H, Shao J, Kirkland SC, Isakson P, Coffey RJ, Morrow J, Beauchamp RD, DuBois RN. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254-2259, 1997.
54. Slice LW, Chiu T, Rozengurt E. Angiotensin II and epidermal growth factor induce cyclooxygenase-2 expression in intestinal epithelial cells through small GTPases using distinct signaling pathways. J Biol Chem 280: 1582-1593, 2005.
55. Sliman SM, Eubank TD, Kotha SR, Kuppusamy ML, Sherwani SI, O'Connor Butler ES, Kuppusamy P, Roy S, Marsh CB, Stern DM, Parinandi NL. Hyperglycemic oxoaldehyde, glyoxal, causes barrier dysfunction, cytoskeletal alterations, and inhibition of angiogenesis in vascular endothelial cells: aminoguanidine protection. Mol Cell Biochem 333: 9-26, 2010.
56. Spak E, Casselbrant A, Olbers T, Lönroth H, Fändriks L. Angiotensin II-induced contractions in human jejunal wall musculature in vitro. Acta Physiol (Oxf) 193: 181-190, 2008.
57. Spencer AU, Yang H, Haxhija EQ, Wildhaber BE, Greenson JK, Teitelbaum DH. Reduced severity of a mouse colitis model with angiotensin converting enzyme inhibition. Dig Dis Sci 52: 1060-1070, 2007.
58. Turker RK, Kayaalp SO. Inhibitory effect of angiotensin on the intestinal motility of the cat and its relation to sympathetic nervous system. Arch Int Physiol Biochim Biophys 75: 735-744, 1967.
59. Usatyuk PV, Vepa S, Watkins T, He D, Parinandi NL, Natarajan V. Redox regulation of reactive oxygen species-induced p38 MAP kinase activation and barrier dysfunction in lung microvascular endothelial cells. Antioxid Redox Signal 5: 723-730, 2003.
60. Wang GD, Wang XY, Hu HZ, Fang XC, Liu S, Gao N, Xia Y, Wood JD. Angiotensin receptors and actions in guinea pig enteric nervous system. Am J Physiol Gastrointest Liver Physiol 289: G614-G626, 2005.
61. Weekley LB. Rat duodenal smooth muscle contractile responses to angiotensin II are dependent on calmodulin. Clin Exp Pharmacol Physiol 17: 99-104, 1990.
62. Wengrower D, Zanninelli G, Pappo O, Latella G, Sestieri M, Villanova A, Faitelson Y, Pines M, Goldin E. Prevention of fibrosis in experimental colitis by captopril: the role of TGF-beta1. Inflamm Bowel Dis 10: 536-545, 2004.
63. Wong TP, Debnam ES, Leung PS. Involvement of an enterocyte renin-angiotensin system in the local control of SGLT1-dependent glucose uptake across the rat small intestinal brush border membrane. J Physiol 584: 613-623, 2007.